HUCMSCs在脊髓损伤细胞移植应用中的研究进展

摘要
图/表
参考文献(44)
相关文章 (15)

全文: PDF (514 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要人脐带间充质干细胞（HUCMSCs）是一种可持续自我更新的全能干细胞，具有很强的迁徙和移植能力，且伦理争议较少，因此备受推广和应用。在脊髓损伤的治疗中，使用HUCMSCs是一种治疗脊髓损伤的新型生物疗法，与手术、药物、康复等常规方法比较，其显示出更好的治疗潜能。然而，目前HUCMSCs应用于脊髓损伤的治疗机制、最佳移植途径和时机仍然存在争议。因此，本文就HUCMSCs在脊髓损伤治疗中的最新研究进展，系统地总结了HUCMSCs的特性及其在脊髓损伤中潜在的神经修复机制和应用，为今后开展HUCMSCs移植的临床转化研究提供依据。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	潘志鹏李思成汤龙姚黎清

关键词 ：人脐带间充质干细胞, 脊髓损伤, 细胞移植

Abstract：Human umbilical cord mesenchymal stem cells (HUCMSCs) is a kind of totipotent stem cells with continuous self-renewal, which have strong ability to delay and transplant and less ethical controversy. Therefore, HUCMSCs have been widely promoted and applied. In the treatment of spinal cord injury, the use of HUCMSCs is a new biological therapy for spinal cord injury, which shows better therapeutic potential compared with conventional methods such as surgery, drugs, and rehabilitation. However, the therapeutic mechanism, optimal transplantation approach, and timing of HUCMSCs in spinal cord injury are still controversial. Therefore, based on the latest research progress of HUCMSCs in the treatment of spinal cord injury, this paper systematically summarizes the characteristics of HUCMSCs and the potential neural repair mechanism and application of HUCMSCs in spinal cord injury, providing a basis for the clinical transformation research of HUCMSCs transplantation in the future.

Key words： Human umbilical cord mesenchymal stem cell Spinal cord injury Cell transplantation

基金资助:国家自然科学基金资助项目（81760414）；
云南省科技计划项目重大科技专项（2018ZF016）。

通讯作者: 姚黎清（1968.12-），女，博士，教授，博士生导师，主任医师；研究方向：神经康复、骨科康复。

作者简介: 潘志鹏（1991.9-），男，昆明医科大学第二附属医院2019级康复医学与理疗学专业在读硕士研究生；研究方向：神经康复、骨科康复。

引用本文:

潘志鹏李思成汤龙姚黎清. HUCMSCs在脊髓损伤细胞移植应用中的研究进展[J]. 中国医药导报, 2021, 18(29): 36-40.
PAN Zhipeng LI Sicheng TANG Long YAO Liqing. Research progress of HUCMSCs in spinal cord injury cell transplantation#br#. 中国医药导报, 2021, 18(29): 36-40.

链接本文:

https://www.yiyaodaobao.com.cn/CN/ 或 https://www.yiyaodaobao.com.cn/CN/Y2021/V18/I29/36

[1] Yuan S，Shi Z，Cao F，et al. Epidemiological Features of Spinal Cord Injury in China：A Systematic Review [J]. Front Neurol，2018，9：683.
[2] Brau RH，Acevedo-Salas Y，Giovannetti K. Epidemiological trends of traumatic brain and spinal cord injury in Puerto Rico from November 10th，2006，through May 24th，2011 [J]. P R Health Sci J，2018，37（2）：67-77.
[3] Bourassa-Moreau ?譩，Mac-Thiong JM，Li A，et al. Do patients with complete spinal cord injury benefit from early surgical decompression？Analysis of neurological improvement in a prospective cohort study [J]. J Neurotrauma，2016，33（3）：301-306.
[4] Baltin ME，Sabirova DE，Kiseleva EI，et al. Comparison of systemic and localized carrier-mediated delivery of methylprednisolone succinate for treatment of acute spinal cord injury [J]. Exp Brain Res，2021，239（2）：627-638.
[5] Sultan I，Lamba N，Liew A，et al. The safety and efficacy of steroid treatment for acute spinal cord injury：A Systematic Review and meta-analysis [J]. Heliyon，2020，6（2）：e03414.
[6] Ho C，Atchison K，Noonan VK，et al. Models of Care Delivery from Rehabilitation to Community for Spinal Cord Injury：A Scoping Review [J]. J Neurotrauma，2021，38（6）：677-697.
[7] Tian D，Deng D，Qiang J，et al. Repair of spinal cord injury in rats by umbilical cord mesenchymal stem cells through P38MAPK signaling pathway [J]. Eur Rev Med Pharmacol Sci，2019，23（3 Suppl）：47-53.
[8] Wu LL，Pan XM，Chen HH，et al. Repairing and Analgesic Effects of Umbilical Cord Mesenchymal Stem Cell Transplantation in Mice with Spinal Cord Injury [J]. Biomed Res Int，2020：7650354.
[9] Sun G，Li G，Li D，et al. hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation [J]. Mater Sci Eng C Mater Biol Appl，2018，89：194-204.
[10] Wang S，Jia Y，Cao X，et al. HUCMSCs transplantation combined with ultrashort wave therapy attenuates neuroinflammation in spinal cord injury through NUR77/ NF-kappaB pathway [J]. Life Sci，2021，267：118958.
[11] Lech W，Sarnowska A，Kuczynska Z，et al. Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton’s Jelly（WJ-MSCs）[J]. Sci Rep，2020，10（1）：16946.
[12] Tao Q，Wu C，Li X，et al. Three-dimensional bio-printed constructs consisting of human umbilical-derived mesenchymal stem cells promote cell viability，proliferation，and differentiation in vitro [J]. Cell Mol Biol （Noisy-le-grand），2020，66（2）：165-171.
[13] Chen H，Wu H，Yin H，et al. Effect of photobiomodulation on neural differentiation of human umbilical cord mesenchymal stem cells [J]. Lasers Med Sci，2019，34（4）：667-675.
[14] Wang H，Ban W，Wang T，et al. miR-20b/106a modulate Ngn2 gene expression during neural differentiation of human umbilical cord mesenchymal stem cells [J]. Neuroreport，2017，28（18）：1225-1231.
[15] Xie Q，Liu R，Jiang J，et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment？[J]. Cell Res Ther，2020，11（1）：1-13.
[16] Krupa P，Vackova I，Ruzicka J，et al. The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application [J]. Int J Mol Sci，2018，19（5）：1503.
[17] Zhang Y，Zhang P，Gao X，et al. Preparation of exosomes encapsulated nanohydrogel for accelerating wound healing of diabetic rats by promoting angiogenesis [J]. Mater Sci Eng C Mater Biol Appl，2021，120：111671.
[18] Hu W，Feng Z，Xu J，et al. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer’s disease rats [J]. Brain Res，2019，1710：61-73.
[19] Bi ZM，Zhou QF，Geng Y，et al. Human umbilical cord mesenchymal stem cells ameliorate experimental cirrhosis through activation of keratinocyte growth factor by suppressing microRNA-199 [J]. Eur Rev Med Pharmacol Sci，2016，20（23）：4905-4912.
[20] Zhang Y，Yang J，Zhang P，et al. Calcitonin gene-related peptide is a key factor in the homing of transplanted human MSCs to sites of spinal cord injury [J]. Sci Rep，2016，6（1）：1-13.
[21] Li J，Wang H，Du C，et al. hUC-MSCs ameliorated CUMS-induced depression by modulating complement C3 signaling-mediated microglial polarization during astrocyte-microglia crosstalk [J]. Brain Res Bull，2020，163：109-119.
[22] Liang L，Wang L，Zhou S，et al. Exosomes derived from human umbilical cord mesenchymal stem cells repair injured endometrial epithelial cells [J]. J Assist Reprod Genet，2020，37（2）：395-403.
[23] Jia Y，Ding X，Zhou L，et al. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1 [J]. Oncogene，2021，40（2）：246-261.
[24] Wang W，Ji Z，Yuan C，et al. Mechanism of Human Umbilical Cord Mesenchymal Stem Cells Derived-Extracellular Vesicle in Cerebral Ischemia-Reperfusion Injury [J]. Neurochem Res，2021，46（3）：455-467.
[25] Zhang Y，Han JJ，Liang XY，et al. miR-23b Suppresses Leukocyte Migration and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting CCL7 [J]. Mol Ther，2018，26（2）：582-592.
[26] Chudickova M，Vackova I，Machova Urdzikova L，et al. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury [J]. Int J Mol Sci，2019，20（18）：4516.
[27] Hu SL，Luo HS，Li JT，et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells [J]. Crit Care Med，2010，38（11）：2181-2189.
[28] Yang CC，Shih YH，Ko MH，et al. Transplantation of human umbilical mesenchymal stem cells from Wharton’s jelly after complete transection of the rat spinal cord [J]. PLoS One，2008，3（10）：e3336.
[29] Zhao ZM，Li HJ，Liu HY，et al. Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats [J]. Cell Transplant，2004，13（2）：113-122.
[30] Yan-Wu G，Yi-Quan K，Ming L，et al. Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury [J]. Neurochem Res，2011， 36（5）：783-792.
[31] Yao M，Li J，Zhang J，et al. Dual-enzymatically cross-linked gelatin hydrogel enhances neural differentiation of human umbilical cord mesenchymal stem cells and functional recovery in experimental murine spinal cord injury [J]. J Mater Chem B，2021，9（2）：440-452.
[32] Kim SU，De Vellis J. Stem cell-based cell therapy in neurological diseases：a review [J]. J Neurosci Res，2009， 87（10）：2183-2200.
[33] Bao CS，Li XL，Liu L，et al. Transplantation of Human umbilical cord mesenchymal stem cells promotes functional recovery after spinal cord injury by blocking the expression of IL-7 [J]. Eur Rev Med Pharmacol Sci，2018，22（19）：6436-6447.
[34] Liao Z，Yang X，Wang W，et al. hucMSCs transplantation promotes locomotor function recovery，reduces apoptosis and inhibits demyelination after SCI in rats [J]. Neuropeptides，2021，86：102125.
[35] Sun L，Wang F，Chen H，et al. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury [J]. Cell Transplant，2019，28（7）：893-906.
[36] Yao S，Liu X，Yu S，et al. Co-effects of matrix low elasticity and aligned topography on stem cell neurogenic differentiation and rapid neurite outgrowth [J]. Nanoscale，2016，8（19）：10252-10265.
[37] Vaquero J，Zurita M，Oya S，et al. Cell therapy using bone marrow stromal cells in chronic paraplegic rats：Systemic or local administration？[J]. Neuroscience Letters，2006， 398（1）：129-134.
[38] Li C，Chen X，Qiao S，et al. Effects of Wharton’s jelly cells of the human umbilical cord on acute spinal cord injury in rats，and expression of interleukin-1beta and nerve growth factor in spinal cord tissues [J]. Artif Cells Nanomed Biotechnol，2016，44（5）：1254-1258.
[39] Dumont AS，Dumont RJ，Oskouian RJ. Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention？[J]. Curr Opin Neurol，2002， 15（6）：713-720.
[40] Vawda R，Badner A，Hong J，et al. Early Intravenous Infusion of Mesenchymal Stromal Cells Exerts a Tissue Source Age-Dependent Beneficial Effect on Neurovascular Integrity and Neurobehavioral Recovery After Traumatic Cervical Spinal Cord Injury [J]. Stem Cells Transl Med，2019，8（7）：639-649.
[41] Yang Y，Cao TT，Tian ZM，et al. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury：Preclinical safety and efficacy study [J]. Exp Cell Res，2020，395（2）：112184.
[42] Okano H，Ogawa Y，Nakamura M，et al. Transplantation of neural stem cells into the spinal cord after injury [J]. Semin Cell Dev Biol，2003，14（3）：191-198.
[43] Chen H，Wang Y，Tu W，et al. Effects of photobiomodulation combined with MSCs transplantation on the repair of spinal cord injury in rat [J]. J Cell Physiol，2021，236（2）：921-930.
[44] Liu J，Han D，Wang Z，et al. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells [J]. Cytotherapy，2013，15（2）：185-191.